StockData
Capricor Therapeutics, Inc. logo

Capricor Therapeutics, Inc. (CAPR) income statement

CAPRNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 6/30
$7.59+0.06 (+0.80%)

Close on Nov 20, 2026Market cap $441.28MP/E –Yield –

See a number that looks wrong?